We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Potential New Sources of Stem Cells

By Biotechdaily staff writers
Posted on 24 May 2002
If proven viable, two new sources of stem cells being investigated would avoid the current controversy surrounding the use of embryonic stem cells for treating disease.

Defective embryos may be one new source of stem cells, according to scientists from the Wellcome Cancer Research Institute at Cambridge University (UK). More...
Dr. John Gurdon and colleagues discovered that defective or abnormal cloned frog embryos produced normal stem cells, which can be manipulated to form any kind of cell in the body. Many of the human embryos that result from in vitro fertilization attempts are also abnormal and are discarded. The scientists believe that some of these may produce normal stem cells.

Another potential source of stem cells under investigation is the human umbilical cord. A neuroscientist at the University of South Florida (USF, Tampa, USA), Tanja Zigova, Ph.D., has been awarded a US$1.3 million grant to study whether stem cells from human umbilical cord blood (HUCB) can treat age-related mental decline and neurodegenerative diseases. Studies suggest that HUCB may be a more readily available source of therapeutic cells for treating Parkinson's or Alzheimer's disease.

Cord blood cells include a significant number of stem cells. Researchers at the USF Center for Aging and Brain Repair have shown that these cells can be reprogrammed to become immature nerve cells. They have also demonstrated that HUCB cells transplanted into the developing brains of neonatal rats begin to look like nerve cells and express certain proteins found only in neurons and glial cells. The new USF study will use a model of aging rats to test which growth and nutritional factors best prompt malleable HUBC cells to become specific types of neurons, to determine if the age of transplant recipients affects the ability of HUBC cells to grow and differentiate, and to determine if HUCB-derived cells transplanted into the brains of aging rats can reverse or slow age-related declines in learning and memory.

"Our ultimate goal is to find out how to turn enough of them into specialized neurons that would read specific cues from the brain, migrate where we want them to go, and produce the types of neurotransmitters that must be replenished to restore nerve function,” said Dr. Zigova, principal investigator.




Related Links:
University of South Florida

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.